Search Results

Displaying Results 6726-6750 of 28402 "'B'"

Jul 14, 2026, 08:17 ET Skyhawk Therapeutics Announces Expansion of its Global Pivotal FALCON-HD Clinical Trial for SKY-0515 in Huntington's Disease to the United States, Canada and the United Kingdom

Symbol Digit Modalities Test (SDMT), and Stroop Word Reading Test (SWRT).The Phase 1/2 trial consists of three parts. Parts A and B evaluated SKY-0515 in Healthy Volunteers. Part C is a randomized, double-blind, placebo-controlled parallel-group study evaluating two dose levels of

More news about: Skyhawk Therapeutics


Jul 14, 2026, 08:08 ET Lemonade Expands Renters Insurance to Maine

claims paid in a matter of seconds. Powered by AI and social impact, Lemonade is a purpose-built, technology-first insurance carrier. A Certified B-Corp, our commitment to social impact is embedded in every aspect of the company, and our Giveback program, which donates a percentage of leftover premiums

More news about: Lemonade, Inc.


Jul 14, 2026, 08:07 ET Always Brings Fibroid Education to ESSENCE Festival of Culture to Advance Menstrual Health Awareness

Fairy®, Febreze®, Gain®, Gillette®, Head & Shoulders®, Lenor®, Olay®, Oral-B®, Pampers®, Pantene®, SK-II®, Tide®, Vicks®, and Whisper®. The P&G community

More news about: Procter and Gamble (P&G)


Jul 14, 2026, 08:00 ET Acurx Pharmaceuticals Announces Scientific Poster Presentation of Ibezapolstat's Microbiome Preservation Data in Multiply-recurrent C. difficile Infection

multicenter, open-label single-arm segment (Phase 2a) study was followed by a double-blind, randomized, active-controlled, non-inferiority, segment (Phase 2b) at 28 US clinical trial sites which together comprise the Phase 2 clinical trial. (see

More news about: Acurx Pharmaceuticals, Inc.


Jul 14, 2026, 08:00 ET Mighty Therapeutics Secures Up to $150 Million to Progress Commercial and Clinical Development of New Class of Mitochondrial Targeted Medicines

provide a credit facility of up to $125 million, including an initial $30 million tranche. The Company has also held an initial closing of its Series B financing, in which founding investor Morningside has invested $25 million.

More news about: Mighty Therapeutics


Jul 14, 2026, 08:00 ET WELLY IS GIVING AWAY BOREDOM THIS SUMMER. ON PURPOSE

life adventures. With bright, kid-friendly designs that stay on through play, Welly believes wearing a bandage is like a badge of honor. As a Certified B Corp brand, Welly is committed to safer, more imaginative childhoods and kids figuring it out as they go. Learn more about the Boredom Box and Welly's

More news about: Welly Health PBC


Jul 14, 2026, 07:58 ET 이루 류, 위산 옌, 요한 W. 콜라, 2026 글로벌 에너지상 수상자로 선정

multimedia:https://www.prnewswire.com/kr/news-releases/uC774uB8E8u002DuB958u002Cu002DuC704uC0B0u002DuC60Cu002Cu002DuC694uD55Cu002Du0077u002Eu002DuCF5CuB77Cu002Cu002Du0032u0030u0032u0036u002DuAE00-302825023.htmlSOURCE

More news about: The Global Energy Association


Jul 14, 2026, 07:33 ET HCL테크, 사상 최대 24억 달러 수주에 힘입어 견조한 1분기 실적 달성

content:https://www.prnewswire.com/kr/news-releases/u0068u0063u006CuD14CuD06Cu002Cu002DuC0ACuC0C1u002DuCD5CuB300u002Du0032u0034uC5B5u002DuB2ECuB7ECu002DuC218uC8FCuC5D0u002DuD798uC785uC5B4u002D-302824992.htmlSOURCE

More news about: HCLTech


Jul 14, 2026, 07:30 ET Illuminare Biotechnologies Appoints Veteran Biopharmaceutical Leader as New CEO

as published in the world-renowned medical journal, JAMA Surgery. Illuminare Biotechnologies also recently completed a Series B funding round which will enable the company to commence and complete a Phase 2 clinical trial in Breast Reconstruction."I am honored to join the

More news about: Illuminare Biotechnologies


Jul 14, 2026, 07:27 ET GlobalMed Logistix Appoints Caroll H. Neubauer to Board of Directors

serving as a member of the Global Management Board of the B. Braun Group of Companies, where he helped grow annual revenue from approximately $1 billion to more than $8 billion. He also led the company's North American operations as chairman and CEO of B. Braun USA, spearheading its transformation into a leading

More news about: GlobalMed Logistix (GMLx)


Jul 14, 2026, 07:23 ET Hamilton Zanze Contributes 10th Multifamily Asset to the HZ Evergreen Fund

Hamilton Zanze (HZ) today announced that The Highlands apartments, a 448-unit Class B+ garden-style community in North Overland Park, Kan., has been contributed to the HZ Evergreen Fund, bringing the Fund's total holdings to 10 properties.

More news about: Hamilton Zanze & Company


Jul 14, 2026, 07:05 ET Indian Deep-Tech Startup Meine Electric's Fast-Charging Iron-Air Battery Clears Independent Validation, Paving the Way for 24/7 Renewable Energy Storage

energy.Mission: Make iron-air batteries the backbone of long-duration storage and lead globally in this category.Long-term goal: Enable $1B in revenue by 2032 through grid-scale Iron-Air Battery deployments.Photo:

More news about: Meine Electric


Jul 14, 2026, 07:00 ET Sabanto and Leaps by Bayer Announce Oversubscribed Series B Financing to Scale Autonomous Technology for Row Crop Farming

July 14, 2026 /PRNewswire/ -- Sabanto, a leader in autonomous retrofit technology for agriculture, today announced an oversubscribed Series B funding led by Leaps by Bayer with participation by Sustainable Forward Capital, InnoVenture Iowa, Fulcrum Global Capital, DCVC, and Yara. The round will

More news about: Sabanto, Inc.


Jul 14, 2026, 07:00 ET Clario Group Acquires Boutique Communications Agency Ted Miller Group to Further Expand Capabilities and Fast Track Growth

executive communications, thought leadership, content development, and strategic storytelling, across a wide range of industries — from consumer and B2B tech to AI, blockchain, gaming, sports, health & fitness, real estate, travel & hospitality, and education.TMG roster of clients have

More news about: Clario Group


Jul 14, 2026, 07:00 ET EVE AIR MOBILITY TOUCHES DOWN AT FARNBOROUGH WITH REAL FLIGHT PROGRESS AND A CLEAR PATH TO CERTIFICATION

MELBOURNE, Fla., July 14, 2026 /PRNewswire/ -- Eve Air Mobility (NYSE: EVEX, EVEXW; B3: EVEB31), a leader in advanced air mobility solutions, arrives at the 2026 Farnborough International Airshow at a defining moment. Its electric Vertical

More news about: Eve Air Mobility


Jul 14, 2026, 07:00 ET OLIN and HUNTSMAN Announce S-4 Registration Statement in Connection with Planned Merger is Effective

and market conditions in the United States and overseas, including economic instability or a downturn in the sectors served by Olin and/or Huntsman; (b) declines in average selling prices for Olin's and/or Huntsman's products and the supply/demand balance for Olin's and/or Huntsman's products, including

More news about: Olin Corporation; Huntsman Corporation


Jul 14, 2026, 06:59 ET Aluminum Plate Market worth $52.95 billion by 2035 - Exclusive Report by MarketsandMarkets™

alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.Today,

More news about: MarketsandMarkets


Jul 14, 2026, 06:30 ET HVAC Filters Market worth $6.21 billion by 2031 - Exclusive Report by MarketsandMarkets™

alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.Today,

More news about: MarketsandMarkets


Jul 14, 2026, 06:30 ET Atrium Therapeutics Announces FDA Clearance of Investigational New Drug Application for ATR 1072 for Treatment of PRKAG2 Syndrome

enroll approximately 37 participants across two parts: Part A, multiple ascending dose cohorts to characterize safety and support dose selection, and Part B, a single-arm expansion cohort at the recommended Phase 2 dose to further evaluate safety and efficacy trends in cardiac structure and function.Clinical

More news about: Atrium Therapeutics


Jul 14, 2026, 06:30 ET Hyperscale Data Bitcoin Treasury Reaches 1,032 Bitcoin Worth Approximately $65.8 Million and Acquired 130 Bitcoin During the Week Ended July 12, 2026

as-converted basis. The Divestiture will occur through the voluntary exchange of the Series F Preferred Stock for shares of Class A Common Stock and Class B Common Stock of ACG (collectively, the "ACG Shares"). The Company reminds its stockholders that only those holders of the Series F Preferred Stock

More news about: Hyperscale Data Inc.


Jul 14, 2026, 06:21 ET ADMA Court News: ADMA Biologics Class Action Lawsuit Alleges Securities Fraud on behalf of Investors with Losses

until August 10, 2026, to ask the Court to be appointed to lead the case. The complaint asserts securities fraud claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in ADMA securities. The class action is pending in the U.S. District Court for

More news about: Bleichmar Fonti & Auld LLP


Jul 14, 2026, 06:17 ET EMBC Court News: Embecta Class Action Lawsuit Alleges Securities Fraud on behalf of Investors with Losses

until August 17, 2026 to ask the Court to be appointed to lead the case. The complaint asserts securities fraud claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Embecta common stock. The class action is pending in the U.S. District Court

More news about: Bleichmar Fonti & Auld LLP


Jul 14, 2026, 06:17 ET GTM Court News: ZoomInfo Class Action Lawsuit Alleges Securities Fraud on behalf of Investors with Losses

until August 24, 2026 to ask the Court to be appointed to lead the case. The complaint asserts securities fraud claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in ZoomInfo securities. The class action is pending in the U.S. District Court

More news about: Bleichmar Fonti & Auld LLP


Jul 14, 2026, 06:17 ET MSFT Court News: Microsoft Class Action Lawsuit Alleges Securities Fraud on behalf of Investors with Losses

until August 11, 2026 to ask the Court to be appointed to lead the case. The complaint asserts securities fraud claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Microsoft common stock. The class action is pending in the U.S. District

More news about: Bleichmar Fonti & Auld LLP


Jul 14, 2026, 06:17 ET PODD Court News: Insulet Class Action Lawsuit Alleges Securities Fraud on behalf of Investors with Losses

until August 31, 2026 to ask the Court to be appointed to lead the case. The complaint asserts securities fraud claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Insulet securities. The class action is pending in the U.S. District Court

More news about: Bleichmar Fonti & Auld LLP


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.